Categories AlphaGraphs, Analysis, Retail
Earnings preview: Cost escalation a major concern for JM Smucker in Q3
From brand building to partnerships, The J.M. Smucker Company (SJM) has been pursuing multiple options to tackle the challenges facing its business. The packaged food maker is slated to deliver results for the third quarter of 2019 on February 26 before the market opens.
Ahead of the quarterly report, market watchers predict that revenues will grow 4% annually to $1.98 billion, reflecting the improved product mix and synergies from the recently acquired Ainsworth Pet Nutrition. However, sales could come under pressure from the divestment of the baking division and rising competition.
Meanwhile, Wall Street is pessimistic about the bottom-line performance, amid concerns over the unfavorable pricing scenario and higher marketing and logistics expenses. Third-quarter profit is forecast to fall by 19% to $2.03 per share. Currently, the consensus analysts’ rating on the company’s stock is hold, while the majority among the remaining analysts recommend sell. The average price target is $101.67.
Wall Street is pessimistic about the bottom-line performance, amid concerns over unfavorable pricing and higher expenses
Taking a cue from its unimpressive performance in the second quarter, when profit and sales fell short of expectations despite a year-on-year increase, the company had lowered its full-year outlook in November last year. Though sales rose 5% to $2 billion in the second quarter it was mainly due to the Ainsworth acquisition, which was partially offset by lower price realizations. The 7.4% earnings growth, to $2.17 per share, came largely from lower expenses.
Of late, food companies are taking the M&A route to sustain growth, while devising strategies to cash in on the popularity of the brands they acquire. In most cases, they depend on external funding due to weakness in cash flow, and the high costs of availing credit often become a burden for them in the long run.
Related: Campbell Soup’s Q1 results beat estimates
The industry is going through a challenging phase, marked by dwindling demand and high transportation and input costs. Also, the companies are constantly under pressure to innovate and revise their business strategies.
Shares of JM Smucker, which have underperformed the market so far this year, closed the last trading session sharply lower. In the past twelve months, the stock maintained a steady downtrend and lost about 19%.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on